• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ST段抬高型心肌梗死患者全身炎症指标与无复流现象的关系

Relationship Between Systemic Inflammation Index and No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction.

作者信息

Çelik Muhammet Cihat, Karayiğit Orhan, Ozkan Can, Dolu Abdullah Kadir, Kalçık Macit

机构信息

Department of Cardiology, 485536Hitit University Erol Olçok Education and Research Hospital, Corum, Turkey.

Department of Cardiology, 233009Yozgat City Hospital, Yozgat, Turkey.

出版信息

Angiology. 2023 Apr;74(4):387-394. doi: 10.1177/00033197221115562. Epub 2022 Jul 20.

DOI:10.1177/00033197221115562
PMID:35857618
Abstract

This study aimed to evaluate the relationship between no-reflow phenomenon and systemic inflammation index (SII) and to compare the predictive capacity of SII together with the neutrophil-lymphocyte ratio (NLR), and the platelet-lymphocyte ratio (PLR) in patients with ST-elevation myocardial infarction (STEMI). A total of 785 patients were included. The thrombolysis in myocardial infarction (TIMI) flow degree has been used to describe the no-reflow phenomenon. The study population was divided into two groups regarding the presence of no-reflow phenomenon including 110 patients with no-reflow (TIMI frame count 0-2) and 675 patients without no-reflow (TIMI frame count 3). The NLR [6.6 (4.6-11.6) vs 3.2 (2.0-5.3); < .001], PLR [175 (121.3-220) vs 102.6 (76.1-150.1); < .001] and SII [1921(1225-2906) vs 738.5 (450.5-1293); < .001] were significantly higher in the no-reflow group. High NLR (OR: 1.078, 95%CI: 1.027-1.397; = .021), PLR (OR: 1.009, 95%CI: 1.003-1.021; = .041) and SII (OR: 1.216, 95%CI: 1.106-1.942; = .004) were found to be independently associated with no-reflow phenomenon. The comparison of the receiver-operating characteristic curves showed that area under the curve of SII was greater than that of NLR (.789 vs .766, = .007) and PLR (.789 vs .759, = .048). SII levels may predict no-reflow phenomenon better than NLR and PLR.

摘要

本研究旨在评估无复流现象与全身炎症指标(SII)之间的关系,并比较SII与中性粒细胞-淋巴细胞比值(NLR)及血小板-淋巴细胞比值(PLR)对ST段抬高型心肌梗死(STEMI)患者无复流现象的预测能力。共纳入785例患者。采用心肌梗死溶栓(TIMI)血流分级来描述无复流现象。根据有无无复流现象将研究人群分为两组,包括110例无复流患者(TIMI帧数0 - 2)和675例无无复流患者(TIMI帧数3)。无复流组的NLR[6.6(4.6 - 11.6)对3.2(2.0 - 5.3);P <.001]、PLR[175(121.3 - 220)对102.6(76.1 - 150.1);P <.001]和SII[1921(1225 - 2906)对738.5(450.5 - 1293);P <.001]显著更高。发现高NLR(OR:1.078,95%CI:1.027 - 1.397;P = .021)、PLR(OR:1.009,95%CI:1.003 - 1.021;P = .041)和SII(OR:1.216,95%CI:1.106 - 1.942;P = .004)与无复流现象独立相关。受试者工作特征曲线比较显示,SII的曲线下面积大于NLR(.789对.766,P = .007)和PLR(.789对.759,P = .048)。SII水平对无复流现象的预测可能优于NLR和PLR。

相似文献

1
Relationship Between Systemic Inflammation Index and No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction.ST段抬高型心肌梗死患者全身炎症指标与无复流现象的关系
Angiology. 2023 Apr;74(4):387-394. doi: 10.1177/00033197221115562. Epub 2022 Jul 20.
2
Correlation of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio with thrombolysis in myocardial infarction frame count in ST-segment elevation myocardial infarction.血小板与淋巴细胞比值及中性粒细胞与淋巴细胞比值与ST段抬高型心肌梗死心肌梗死溶栓帧数的相关性
Eur J Clin Invest. 2017 Apr;47(4):322-327. doi: 10.1111/eci.12736. Epub 2017 Mar 6.
3
The combination of neutrophil-to-lymphocyte ratio and platelet correlation parameters in predicting the no-reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.中性粒细胞与淋巴细胞比值及血小板相关参数联合预测 ST 段抬高型心肌梗死患者直接经皮冠状动脉介入治疗后无复流现象。
Scand Cardiovasc J. 2020 Dec;54(6):352-357. doi: 10.1080/14017431.2020.1783457. Epub 2020 Jun 29.
4
Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.入院时红细胞分布宽度-血小板比值对接受直接经皮冠状动脉介入治疗的急性ST段抬高型心肌梗死患者无复流现象的预测价值
Cardiol J. 2016;23(1):84-92. doi: 10.5603/CJ.a2015.0070. Epub 2015 Oct 27.
5
Platelet-Lymphocyte ratio is a predictor for the development of no-reflow phenomenon in patients with ST-segment elevation myocardial infarction after thrombus aspiration.血小板-淋巴细胞比值是 ST 段抬高型心肌梗死患者血栓抽吸后无复流现象发展的预测因子。
J Clin Lab Anal. 2021 Jun;35(6):e23795. doi: 10.1002/jcla.23795. Epub 2021 May 4.
6
Relationship between intracoronary thrombus burden and systemic immune-inflammation index in patients with ST-segment elevation myocardial infarction.ST段抬高型心肌梗死患者冠状动脉内血栓负荷与全身免疫炎症指标的关系
Acta Cardiol. 2023 Feb;78(1):72-79. doi: 10.1080/00015385.2022.2035082. Epub 2022 Feb 1.
7
Systemic immune-inflammation index predicts no-reflow phenomenon after primary percutaneous coronary intervention.全身免疫炎症指数预测直接经皮冠状动脉介入治疗后无复流现象。
Acta Cardiol. 2022 Feb;77(1):59-65. doi: 10.1080/00015385.2021.1884786. Epub 2021 Feb 22.
8
The Systemic Immune-Inflammation Index Predicts Impaired Myocardial Perfusion and Short-Term Mortality in ST-Segment Elevation Myocardial Infarction Patients.系统性免疫炎症指数预测 ST 段抬高型心肌梗死患者心肌灌注受损和短期死亡率。
Angiology. 2023 Apr;74(4):365-373. doi: 10.1177/00033197221106886. Epub 2022 Jun 7.
9
Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.血小板与淋巴细胞比值对急性 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后血管造影再通的预测价值。
Am J Cardiol. 2014 Aug 1;114(3):342-7. doi: 10.1016/j.amjcard.2014.04.045. Epub 2014 May 15.
10
[Relation of admission neutrophil/lymphocyte ratio to angiographic no-reflow phenomenon in patients with ST-elevated myocardial infarction undergoing primary coronary intervention].[ST段抬高型心肌梗死患者接受直接冠状动脉介入治疗时入院中性粒细胞/淋巴细胞比值与血管造影无复流现象的关系]
Zhonghua Liu Xing Bing Xue Za Zhi. 2014 Jul;35(7):856-60.

引用本文的文献

1
Association Between the Serum Uric Acid to Albumin Ratio and the No-Reflow Phenomenon After Percutaneous Coronary Intervention (PCI): A Systematic Review and Meta-Analysis.血清尿酸与白蛋白比值与经皮冠状动脉介入治疗(PCI)后无复流现象的关联:一项系统评价和荟萃分析
Cureus. 2025 Apr 4;17(4):e81712. doi: 10.7759/cureus.81712. eCollection 2025 Apr.
2
Predictive value of the triglyceride-glucose index for no-reflow phenomenon after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction complicated by metabolic syndrome.急性ST段抬高型心肌梗死合并代谢综合征患者经皮冠状动脉介入治疗后甘油三酯-葡萄糖指数对无复流现象的预测价值
Am J Transl Res. 2024 Oct 15;16(10):5539-5551. doi: 10.62347/HQVS4428. eCollection 2024.
3
Correlations Between Acute Coronary Syndrome and Novel Inflammatory Markers (Systemic Immune-Inflammation Index, Systemic Inflammation Response Index, and Aggregate Index of Systemic Inflammation) in Patients with and without Diabetes or Prediabetes.糖尿病或糖尿病前期患者与非糖尿病或非糖尿病前期患者中急性冠状动脉综合征与新型炎症标志物(全身免疫炎症指数、全身炎症反应指数和全身炎症综合指数)之间的相关性
J Inflamm Res. 2024 Apr 29;17:2623-2632. doi: 10.2147/JIR.S454117. eCollection 2024.
4
Effects of ondansetron treatment on outcomes of critically ill patients with myocardial infarction partly through its anti-inflammatory activity.昂丹司琼治疗对心肌梗死后危重症患者结局的影响部分是通过其抗炎活性实现的。
Int J Med Sci. 2023 Apr 17;20(6):709-716. doi: 10.7150/ijms.81797. eCollection 2023.